Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
47,224,280
-
Share change
-
-5,143,591
-
Total reported value
-
$156,736,746
-
Put/Call ratio
-
114%
-
Price per share
-
$3.32
-
Number of holders
-
62
-
Value change
-
-$38,362,555
-
Number of buys
-
28
-
Number of sells
-
34
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q2 2021
As of 30 Jun 2021 Aptose Biosciences Inc. - Common Shares had 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,224,280 shares of stock of the company.
Largest 10 holders included DRW Securities, LLC, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, First Light Asset Management, LLC, Cormorant Asset Management, LP, Polar Capital Holdings Plc, EVENTIDE ASSET MANAGEMENT, LLC, 683 Capital Management, LLC, Opaleye Management Inc., and SANDERS MORRIS HARRIS LLC.
This table shows 63 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.